Sign in
Taking people in United StatesNo phase

Ankle-foot braces for walking and balance in Charcot-Marie-Tooth disease with high-arched feet

Tests ankle-foot orthoses for walking and balance in people with Charcot-Marie-Tooth disease.

Key facts

Who runs it
Bopha Chrea
Where
North Liberty, United StatesSee the site
Trial code
Registry title
CMT Gait, Mobility, Balance - AOFAS Grant
Status
Recruiting
People taking part
66 people, planned
Started
14 Aug 2025
Expected to end
Jan 2027
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Ankle-foot Orthoses
Record updated
23 September 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with Charcot-Marie-Tooth disease (CMT) and a high-arched, inward-turned foot (cavovarus foot). It compares people who wear an ankle-foot brace (AFO) with people who had foot surgery.

Age
The criteria say 12 to 75 years. The registry age fields say 25 to 55 Years.
Sex
All sexes can join.
Disease stage
CMT diagnosed by a doctor and confirmed by a gene test. People must be able to walk at a slow to moderate pace without an AFO.
Earlier treatment
Non-surgery group: must have an AFO prescribed for daily activities and no past surgery to correct the cavovarus foot. Surgery group: must have had surgery to correct the cavovarus foot, focused on muscle balancing and hindfoot correction.
Biomarker or test result
Genetic confirmation of CMT.

Main reasons for not taking part

  • Other causes or risk factors for nerve damage, such as diabetes or alcohol abuse
  • Vision problems that are not corrected
  • Past bone or muscle injury that needed surgery
  • Loss of protective feeling in the sole of the foot
  • Pain above 4/10 while walking, or pain rising more than 2/10 during testing

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 25 and 55 years old?

Where in United States

  • University of Iowa Medical Campus - North Liberty (MCNL)North Liberty, United StatesContact: Bopha Chrea, MDTaking people

About the trial

What the trial wants to find out

The overall objective of the proposed research is to begin to better understand the potential benefits and limitations of ankle -foot orthosis (AFO) use in the context of mobility and balance during gait for individuals with Charcot-Marie-Tooth disease (CMT). These benefits will be studied in comparison to those offered by surgical correction. We will accomplish by having subjects undergo mobility and balance tests in our gait analysis lab.

The 2 groups in the trial

  • OPNo study treatment, for comparison

    Charcot-Marie-Tooth patients who have undergone surgical correction but do not wear ankle-foot orthoses.

  • NonOPOther group

    Charcot-Marie-Tooth patients who have not undergone surgical correction, but do wear clinically prescribed ankle-foot orthoses. NonOP subjects will complete study procedures both with and without their AFOs.

    Treatment: Ankle-foot Orthoses

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Lower Extremity Gait, Mobility and Balance Confidence in Charcot-Marie-Tooth Patients With Cavovarus Foot Deformity
Plain-language title
Ankle-foot braces for walking and balance in Charcot-Marie-Tooth disease with high-arched feetGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT07188415, who can take part
Record updated
23 September 2025